As pharmaceutical companies push changes to the 340B drug pricing program, safety-net hospitals serving Black and low-income ...
Johnson & Johnson, Eli Lilly, Sanofi and Bristol Myers Squibb are suing the federal government over the future of their 340B drug rebate plans. The lawsuits reflect rising tensions among drugmakers, ...
Newsmax on MSNOpinion
Trump puts drug pricing program fraudsters on notice
Trump Puts Drug Pricing Program Fraudsters on Notice ...
The American Hospital Association (AHA) writes to alert you to the latest development in connection with the growing number ...
This spring, Minnesota state lawmakers are considering legislation to further enforce compliance with the 340B program, which ...
The 340B Drug Discount Program was designed to help safety-net providers make drugs available to low-income patients and earn revenue. Drug manufacturers have put restrictions on which pharmacies ...
The 340B program is criticized for generating revenue rather than solely aiding underinsured patients, impacting community providers and Medicare patients. Pharmaceutical companies face challenges ...
Minnesota's Legislature is reckoning with 340B, a prescription medication discount program for nonprofit hospitals, for ...
On December 29, 2025—just three days before the 340B Rebate Model Pilot Program (the Rebate Program) was set to begin—the U.S. District Court for the District of Maine issued an order granting a ...
Drug manufacturers participating in the Section 340B Drug Pricing Program now face a significant new litigation risk under the False Claims Act (“FCA”). In a recent decision, Adventist Health System v ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results